Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France
A Bénard-Laribière, A Pariente, E Pambrun… - BMJ open, 2017 - bmjopen.bmj.com
Objectives To study trends in use of oral glucocorticoids (GCs) among adults, characteristics
of oral GC initiators and prescriptions for the prevention of potential adverse effects …
of oral GC initiators and prescriptions for the prevention of potential adverse effects …
Systemic glucocorticoid use in Denmark: a population-based prevalence study
K Laugesen, JOL Jørgensen, HT Sørensen… - BMJ open, 2017 - bmjopen.bmj.com
Objectives Glucocorticoid (GC) use is widespread and associated with many adverse
effects. Thus, it is important to ascertain GC utilisation patterns. In this study, we examined …
effects. Thus, it is important to ascertain GC utilisation patterns. In this study, we examined …
Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark
K Laugesen, JOL Jørgensen, I Petersen… - European Journal of …, 2019 - academic.oup.com
Objective Glucocorticoid treatment of inflammatory disorders is associated with significant
adverse effects related to glucocorticoid excess as well as adrenal insufficiency. This …
adverse effects related to glucocorticoid excess as well as adrenal insufficiency. This …
High mortality rate in oral glucocorticoid users: a population-based matched cohort study
MJ Einarsdottir, P Ekman, M Molin, P Trimpou… - Frontiers in …, 2022 - frontiersin.org
Objective The aim of the study was to investigate all-cause and disease-specific mortality in
a large population-based cohort of oral glucocorticoid (GC) users. Methods This was a …
a large population-based cohort of oral glucocorticoid (GC) users. Methods This was a …
Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years
L Fardet, I Petersen, I Nazareth - Rheumatology, 2011 - academic.oup.com
Objective. To assess trends in long-term (ie≥ 3 months) oral glucocorticoid (GC)
prescriptions over the past 20 years. Methods. Data of UK adult patients registered between …
prescriptions over the past 20 years. Methods. Data of UK adult patients registered between …
Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients
C Morin, L Fardet - Clinical rheumatology, 2015 - Springer
Despite systemic glucocorticoids are widely used, risk factors for most of their adverse
events and patients' beliefs about the drug are poorly known. An online survey was …
events and patients' beliefs about the drug are poorly known. An online survey was …
Monitoring long-term oral corticosteroids
L Mundell, R Lindemann, J Douglas - BMJ open quality, 2017 - bmjopenquality.bmj.com
Corticosteroids are synthetic analogues of human hormones normally produced by the
adrenal cortex. They have both glucocorticoid and mineralocorticoid properties. The …
adrenal cortex. They have both glucocorticoid and mineralocorticoid properties. The …
Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort study
L Fardet, I Petersen, I Nazareth - Medicine, 2015 - journals.lww.com
Monitoring of Patients on Long-Term Glucocorticoid Therapy:... : Medicine Monitoring of
Patients on Long-Term Glucocorticoid Therapy: A Population-Based Cohort Study : Medicine …
Patients on Long-Term Glucocorticoid Therapy: A Population-Based Cohort Study : Medicine …
The epidemiology of glucocorticoid-associated adverse events
AK McDonough, JR Curtis, KG Saag - Current opinion in …, 2008 - journals.lww.com
The epidemiology of glucocorticoid-associated adverse events : Current Opinion in
Rheumatology The epidemiology of glucocorticoid-associated adverse events : Current Opinion …
Rheumatology The epidemiology of glucocorticoid-associated adverse events : Current Opinion …
Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance database
S Trijau, G De Lamotte, V Pradel, F Natali… - RMD open, 2016 - rmdopen.bmj.com
Introduction Long-term glucocorticoid therapy is the leading cause of secondary
osteoporosis. The management of glucocorticoid-induced osteoporosis (GIOP) seems to be …
osteoporosis. The management of glucocorticoid-induced osteoporosis (GIOP) seems to be …